glp-1 drugs and gastroparesis How Dangerous Is Gastroparesis? How do the GI effects

Key Benefits Observed: Significant weight loss: substantial and sustained reductions in body weight have been observed Appetite Suppression: satiety signals have been observed to spike, leading to vastly reduced caloric consumption

PubChem Compound Summary for CID 5281224, Astaxanthin

In neuroblastoma cells, Epitalon reduced levels of 8-hydroxydeoxyguanosine (8-OHdG), a key marker of oxidative DNA damage that accumulates in aging neurons and is elevated in Alzheimers and Parkinsons disease [51]

We included peer-reviewed randomized controlled trials, meta-analyses, and high-quality narrative or systematic reviews written in English that evaluated the effects of GLP-1 receptor agonists (liraglutide, semaglutide, or related analogues), as well as dual GIP/GLP-1 receptor agonists (such as tirzepatide), exercise training, or their combination on weight loss, body composition, metabolic, or cardiovascular outcomes in adults with obesity or type 2 diabetes